INTRODUCTION
============

The gastrointestinal (**GI**) microbiota is a complex collection of microorganisms (i.e., bacteria, archaea, fungi, protozoa, and viruses). Recent molecular phylogenetic studies, typically based on comparative 16S rRNA gene analysis, have revealed that the GI tract of mammals harbors several hundred to thousand bacterial phylotypes ([@r19]; [@r66]; [@r23]). It is estimated that the intestine of mammals contains approximately 10^10^ to 10^14^ microorganisms, about 10 times more than the number of cells composing the host body. This mutually interacting system composed of the host cells and the resident microbes is called the intestinal microbiome. Gut microbes play a crucial role in host health. They act as a defending barrier against invading pathogens, aid in digestion and energy harvest from the diet, provide nutritional support for enterocytes, and stimulate the development of the immune system. Molecular approaches have improved our understanding about the composition, the dynamics, and the functionality of the intestinal ecosystem in dogs and cats ([@r53]; [@r16]; [@r72]). The composition of the intestinal microbiota can be influenced to some extent by exogenous factors, such as diet ([@r59]; [@r2]; [@r47]). However, the microbiota is resilient to most environmental influences, returning rapidly to its pretreatment state. Antibiotic administration leads to more profound alterations in the intestinal microbiome, with some bacterial groups remaining depressed for several weeks to months ([@r17]; [@r66]; [@r22]). During the last few years, convincing evidence has emerged implicating alterations in the composition of the intestinal microbiota to chronic enteropathies not only in humans, but also in dogs and cats ([@r20]; [@r27]; [@r28]; [@r13]; [@r70]). In addition, extraintestinal disorders (e.g., atopy in infants) have been, due to the interactions of intestinal microbiota with the host immune system, associated with GI dysbiosis ([@r51]). These findings emphasize the importance of maintaining a balanced intestinal ecosystem. This article will summarize recent work characterizing the intestinal microbiome of healthy cats and dogs, and alterations in the composition of the intestinal microbiota and innate immune system that have been identified in dogs and cats with chronic enteropathies.

CHARACTERIZATION OF THE INTESTINAL MICROBIOTA
=============================================

Traditional cultivation techniques have commonly been used to characterize the composition of the canine and feline intestinal microbiota ([@r6]; [@r32]; [@r46]). Bacterial culture is useful for the detection of specific intestinal pathogens (e.g., *Salmonella* spp.), allowing for antibiotic susceptibility testing and genotyping of cultured isolates. However, it is now well established that culture-dependent methods are not well suited for in-depth characterization of complex environments, such as the mammalian GI tract. Limitations of cultivation methods include our inability to culture and correctly classify the vast majority of intestinal microbes ([@r21]). Molecular tools have now become the standard approach in microbial ecology ([Figure 1](#f1){ref-type="fig"}) and are now increasingly used for characterization of the intestinal microbiome of dogs and cats ([@r69]; [@r16]; [@r37]; [@r78]). These molecular methods have been reviewed in detail elsewhere ([@r73]).

![Molecular methods for characterization of the intestinal microbiome. Amplification of the 16S rRNA gene by PCR allows either direct identification of bacterial phylotypes or the creation of a molecular fingerprint representing the bacterial diversity in a sample. New metagenomic and transcriptomics approaches, based on high-throughput sequencing of DNA or mRNA without prior amplification of a specific gene, yield an overview of the gene content of the sample and therefore the functional properties of the intestinal microbiome (DGGE = denaturing gradient gel electrophoresis; T-RFLP = terminal RFLP).](jas3377-f1){#f1}

THE INTESTINAL MICROBIOME OF DOGS AND CATS
==========================================

Because of anatomical and physiological differences, each intestinal compartment harbors a unique microbial ecosystem ([@r69]). Microorganisms reside in specialized niches and provide specialized functions by utilizing host nutrients and, in return, provide metabolites for host uptake ([Table 1](#t1){ref-type="table"}). Each dog and cat harbors a very unique and individual microbial profile ([@r68]; [@r52]). The major individual differences occur on a bacterial species and strain level, with typically only minor overlap of bacterial species between individual animals. A recent study has shown that 84% of cats evaluated harbored *Bifidobacterium* spp. ([@r52]). However, only a minor percentage of cats harbored the same species of Bifidobacteria. Differences in bacterial composition between dogs and cats have been suggested ([@r32]; [@r31]). New molecular studies indicate that such differences manifest themselves on a bacterial species and strain level, as most mammals share similar bacterial phyla and genera ([@r36]).

###### 

Functions of the intestinal microbiota in the normal gastrointestinal tract

  Microbial activity                              Products                                                                     Representatives
  ----------------------------------------------- ---------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------
  Decarboxylation, deamination of AA              Ammonia                                                                      *Clostridium* spp., *Peptostreptococcus* spp., *Peptococcus* spp.
  Deconjugation/dehydroxylation of bile acids     Secondary bile acids (cholate/deoxycholate)                                  *Clostridium hiranonis*, *Lactobacillus* spp.
  Vitamin synthesis                               Vitamin K~2~, B~12~, biotin, folate                                          *Enterococcus* spp., *Pseudomonas* spp., *Sphingomonas* spp., *Lactobacillus* spp.
  Carbohydrate fermentation                       Lactate, propionate, acetate, butyrate                                       *Clostridium* cluster XIVa, *Prevotella* spp., *Faecalibacterium* spp., *Bifidobacterium* spp.
  AA fermentation                                 Hydrogen, methane, amines, phenols, NH~3~, organic acids, hydrogen sulfite   Sulfate-reducing bacteria (SRB), *Desulfovibrio* spp., *Clostridium* spp., *Peptostreptococcus* spp.
  Degradation of oxalate                          Formate and CO~2~                                                            *Oxalobacter formigenes*
  Inulin and starch degradation                   Lactate                                                                      *Bifidobacterium* spp.
  Metabolism of H~2~, alcohols, and acetic acid   Methane and CO~2~                                                            Methanobacteria

Differences exist also in composition and in total bacterial numbers in the different compartments of the GI tract ([Table 2](#t2){ref-type="table"}). Total bacterial counts and species richness increase along the GI tract and vary also between the intestinal lumen and the mucosa ([@r46]). The stomach harbors between 10^1^ and 10^6^ cfu/g of bacteria. Bacterial counts in the duodenum and jejunum are typically small (10^5^ cfu/mL of content), but can reach up to 10^9^ cfu/mL in some dogs and cats ([@r31]). This is considerably greater than found in the duodenum of humans, where total bacterial counts \>10^5^ cfu/g have been associated with the clinical syndrome small intestinal bacterial overgrowth. Cats appear to have greater counts of anaerobic bacteria in their small intestine compared with dogs ([@r32]). The distal small intestine (i.e., ileum) contains a more diverse microbiota and greater bacterial numbers (10^7^ cfu/mL). Bacterial counts in the colon range between 10^9^ and 10^11^ cfu/g of content ([@r6]; [@r46]). *Bacteroides*, *Clostridium*, *Lactobacillus*, *Bifidobacterium* spp., and Enterobacteriaceae are the predominant bacterial groups that have been cultured from the canine and feline intestine ([Table 2](#t2){ref-type="table"}).

###### 

Predominant bacterial groups in the canine and feline gastrointestinal tract^1^

  Location          Culture results^1^           16S rRNA gene results^2^  FISH^3^                                                                 
  ----------------- --------------------------- -------------------------- ----------------------- ------------ ------------------------- -------- ------------
  Small intestine                                                                                                                                  
                    Spiral-shaped rods                  3.0 to 6.8         Clostridiales             30 to 50                             N/A^4^   
                    *Bacteroides*                        0 to 5.5          Enterobacteriales         20 to 60                             N/A      
                    *Lactobacillus* sp.                 1.0 to 5.4         Lactobacillales           5 to 30                              N/A      
                    *Streptococcus* spp.                3.0 to 5.2         Bacteroidales              0 to 5                              N/A      
                    *Escherichia coli*                  2.3 to 5.0         Campylobacterales          0 to 2                              N/A      
                    *Clostridium perfringens*           1.0 to 2.5         Actinomycetales            0 to 3                              N/A      
                                                                           Fusobacteriales           0 to 10                              N/A      
                                                                           Pasteurellales             2 to 5                              N/A      
                                                                           Spirochaetes              0 to 12                              N/A      
  Large intestine                                                                                                                                  
                    *Bacteroides*                      7.3 to 10.2                                                                                 
                    *Bifidobacterium* spp.             8.0 to 10.0         Aeromonadales            0.2 to 0.5  *Bacteroides* spp.                 9.1
                    *C. perfringens*                    5.5 to 8.0         Bacteroidales            0.5 to 35   *Bifidobacterium* spp.             8.3 to 9.3
                    *Clostridium* spp.                  7.3 to 9.5         *Bifidobacterium* sp.       N/A      C. cluster IX                      8.3
                    *E. coli*                           6.4 to 8.6         Coriobacteriales          1 to 2.5   C. cluster XI                      8.03
                    *Lactobacillus* spp.                5.5 to 9.0         Clostridiales             10 to 78   *C. histolyticum* group            7.9 to 8.0
                    Prevotella                          7.0 to 8.5         Enterobacteriales         0.1 to 2   *Desulfovibrio*                    7.3
                    Ruminococcus                        7.0 to 8.0         Erysipelotrichales         0 to 8    *Escherichia coli*                 6.9
                    *Staphylococcus* spp.               5.2 to 5.3         Fusobacteriales          0.3 to 25   *Eubacterium*                      9.2
                    *Streptococcus* spp.                8.8 to 9.1         Lactobacillales            1 to 5    *Lactobacillus*                    8.6 to 9.4

^1^ [@r15]; [@r6]; [@r32]; [@r46].

^2^ [@r53], [@r52]; [@r65], [@r66].

^3^ [@r27]; [@r30]. FISH = fluorescence in situ hybridization.

^4^N/A = not applicable.

Molecular tools have greatly expanded our knowledge about the phylogenetic diversity within the canine and feline gut. Recent studies have revealed several hundred bacterial phylotypes in the canine intestinal tract ([@r66]; [@r72]). The phyla Firmicutes, Bacteroidetes, Proteobacteria, Fusobacteria, and Actinobacteria constitute more than 99% of all gut microbiota in dogs and cats. The remaining bacterial groups are represented by the phyla Spirochaetes, Tenericutes, Verrucomicrobia, Cyanobacteria, Chloroflexi, and a few unclassified bacterial lineages. Generally, aerobic bacteria or facultative anaerobic bacteria occur in greater abundance in the small intestine, whereas anaerobes predominate in the large intestine. In the stomach, mucosa-adherent *Helicobacter* spp. predominate, followed by *Lactobacillus* and *Streptococcus* spp., and *Clostridia* spp. Whereas the vast majority of cats and dogs harbor various *Helicobacter* spp. in their stomach, *Helicobacter pylori*, the clinically most important *Helicobacter* species in humans, has not been isolated from pet dogs or cats ([@r55]). The proximal small intestine harbors approximately 10 different bacterial phyla, with Clostridia, Lactobacillales, and Proteobacteria being most abundant ([@r66]). Proteobacteria and Spirochaetes are more abundant in the proximal GI tract and typically represent \<1% of obtained sequences in the large intestine of healthy animals. Firmicutes, *Bacteroides*, and Fusobacteria appear to be the predominant bacterial groups in the large intestine. However, the reported abundance of these bacterial groups differs between studies. For example, percentages of Firmicutes range between 25 and 95% of obtained sequencing tags ([@r47]; [@r52]; [@r72]; [@r23]). It is likely that these discrepancies may be due to differences in DNA extraction methods and PCR protocols between studies. Actinobacteria were identified as highly abundant in fecal samples using comparative chaperonin 60 gene sequence analysis and fluorescence in situ hybridization ([@r27]; [@r16]; [@r30]). This is not surprising, because it has been shown that 16S rRNA gene approaches with universal bacterial primers typically underestimate Actinobacteria ([@r52]). Bifidobacteria, members of the Actinobacteria appear to be less abundant in cats and dogs compared with humans ([@r27]; [@r30]).

The Firmicutes are a heterogeneous bacterial phylum, comprising several distinct phylogenetically *Clostridium* clusters. These clusters differ in abundance along the intestinal tract. Clusters XIVa and IV encompass many important short-chain fatty acids (**SCFA**) producing bacteria (e.g., *Ruminococcus* spp., *Faecalibacterium* spp., *Dorea* spp., and *Turicibacter* spp.) and predominate in the ileum and colon. Cluster XI and Cluster I (*Clostridium perfringens*-group) are the second most abundant group in the small and large intestine of dogs and cats ([@r53]; [@r65]).

Several studies have described the metabolic products generated by the canine and feline intestinal microbiota, including VFA, lactate, ammonia, and other end products ([@r71]; [@r63]; [@r75]). Of significance for GI health is the ability of intestinal microbes to ferment dietary products into SCFA ([@r76]). Of those, acetate, propionate, and butyrate are most abundant, constituting approximately 60, 25, and 10%, respectively, of VFA in the canine and feline fecal samples ([@r71]; [@r2]). Minor components of the VFA are branched-chain fatty acids, including isobutyric acid, butyric acid, and isovaleric acid, which are formed during protein degradation ([@r39]; [@r2]).

Although marked differences in the phylogenetic composition of the intestinal microbiota have been observed between individual animals of the same animal species, the metabolic end products are typically quite similar between individuals. Recent metagenomics studies have revealed that despite phylogenetic differences, individuals share a wide array of microbial genes, indicating that the human intestine harbors a core microbiome ([@r77]). Furthermore, it is suggested that a functional redundancy exists in the GI tract. Several members of the community are able to perform similar functions, and if one microbial group is displaced because of perturbations (e.g., antibiotic therapy), other members of the community are capable of maintaining a stable ecosystem function ([@r17]; [@r66]). The core microbiome has not been well defined in dogs and cats.

FUNGI, ARCHAEA, AND VIRUSES
===========================

The mammalian GI tract harbors complex communities of fungi, archaea, protozoa, and viruses. Recent molecular studies have provided more in-depth analysis about the diversity of these microorganisms in healthy animals, but their interactions, their influences on the host, and their role in GI disease remain unclear. Cultivation studies have reported yeasts and molds in the intestine of approximately 25% healthy Beagle dogs ([@r15]; [@r46]). Molecular tools have revealed fungi in the small intestine of 76% of the dogs evaluated ([@r67]). A recent metagenomic approach estimated the abundance of fungi in canine fecal samples as \<0.1% of total microbiota ([@r72]).

Archaea are single-celled microorganisms and are evolutionary distinct from bacteria and eukaryotes. Archaea are commensals in the intestine of ruminants and have recently been described in the human and canine intestine, with Methanobacteriales most commonly reported, representing approximately 1% of total microbioal sequencing tags ([@r72]).

Reported viruses in the GI tract of dogs and cats are limited to a few families, such as rotavirus, coronavirus, and parvovirus ([@r35]). New metagenomic studies revealed a highly diverse viral community in the canine intestine, composed of several hundred double-stranded DNA viruses, with the vast majority classified as bacteriophages ([@r72]). Future studies will need to evaluate the prevalence and abundance of single-stranded DNA and RNA viruses in the canine and feline GI tract.

CONTRIBUTION OF THE INTESTINAL MICROBIOTA TO GASTROINTESTINAL HEALTH AND DISEASE
================================================================================

A balanced intestinal ecosystem primes and stimulates the immune system, aids in the defense against invading intestinal pathogens, and provides nutritional benefits to the host. Although animals can be raised under germ-free conditions, several morphological and immunological differences between germ-free and conventionally raised animals indicate that commensal microbes contribute significantly to the development and maintenance of gut structure. For example, germ-free rodents have an altered epithelial architecture (e.g., thinner lamina propria, reduced number of Peyer\'s patches, and lymphoid follicles) and have a reduced turnover time of epithelial cells ([@r25]). Dogs raised germ-free show similar growth rates as conventionally raised dogs, but they demonstrate an underdeveloped lymphoid system and have decreased immunoglobulin concentrations ([@r11]). However, germ-free dogs are capable of mounting an adequate immune response to antigenic stimulation. Wound healing and blood-clotting mechanisms in germ-free-raised dogs are similar as in conventionally raised animals ([@r11]). The intestine of germ-free dogs is characterized by thinner villi and a reduction in both the lamina propria and mucosal surface area ([@r74]). Interestingly, surgically induced strangulation obstruction of the small intestine and surgically induced bile peritonitis did not lead to death in germ-free-raised dogs, whereas conventionally raised dogs showed 100% mortality, emphasizing the role of intestinal bacteria for the severity of the disease ([@r11]).

The resident microbiota is an integral part of the intestinal barrier, which protects the host from invading pathogens, a mechanism termed colonization resistance. The proposed mechanisms include the competition for oxygen, nutrients, mucosal adhesion sites, and the creation of a physiologically restrictive environment for nonresident bacterial species (e.g., secretion of antimicrobials, alterations in gut pH, production of hydrogen sulfide; [@r34]). Therefore, young dogs and cats with colonization resistance not yet fully established are typically more susceptible to invading pathogens (e.g., *Campylobacterjejuni*). The sterile GI tract of newborn puppies and kittens is colonized within hours after birth by bacteria present in the birth canal and surrounding environment. After 24 h, aerobic and anaerobic counts exceed 10^8^ cfu/g of intestinal content ([@r9]). Aerobic and anaerobic bacteria are at similar numbers in the first weeks after birth, but the proportions of anaerobes are greater during adulthood ([@r9]). The presence of intestinal bacteria in early life is necessary to establish oral tolerance to commensal bacteria and food antigens, to prevent onset of an inappropriate immune response, which may lead to chronic GI inflammation ([@r4]). Microbes interact and stimulate the immune host system, as has been shown by administration of specific bacterial strains as probiotics in dogs and cats. For example, administration of *Lactobacillus acidophilus* DSM13241 increased granulocyte phagocytic activity ([@r42]). Growing puppies that received *Enterococcus faecium* SF68 for 20 wk showed increased plasma IgA concentrations compared with the control group ([@r7]).

The majority of colonic bacteria are anaerobes and their main functions are to produce energy from food and to help in the competitive exclusion of potentially pathogenic bacteria. The slower flow of ingesta and the increased time and availability of nutrients favors the microbial diversity in the colon. Bacteria within the ecosystem have developed cooperative strategies to transform the complexity of nutrients for their own benefit as well as that of the host. Colonic bacteria provide digestive enzymes that allow the utilization of complex carbohydrates. Microbes metabolize sloughed epithelial cells, endogenous mucus, and nondigested substrates that have passed through the small intestine. The latter are predominantly complex carbohydrates, including starch and dietary fiber, such as cellulose, pectin, and fructans ([@r76]). The fermentation of these substrates results in the production of SCFA (e.g., acetate, propionate, and butyrate) that provide the energy for bacterial metabolism but also for epithelial cell growth ([@r71]). Up to 7% of the metabolic energy of dogs, and to a lesser extent in cats, is produced by microbial fermentation in the colon ([@r24]; [@r8]). The fecal concentrations of microbial metabolic products can be modified through dietary modulation, such as varying protein or fiber content (e.g., through prebiotic supplementation) in the diet ([@r26]; [@r2]).

Normal intestinal motility is a major defense mechanism against attachment of pathogenic bacteria in the small intestine, and subnormal intestinal motility has been associated with small intestinal dysbiosis. Physiological concentrations of SCFA stimulated intestinal motility in the canine ileum, emphasizing the importance of microbial fermentation products on host health ([@r33]). In vitro studies in dogs and cats revealed that physiological concentrations of SCFA stimulate contraction of longitudinal, but not circular smooth muscles in the canine and feline colon, indicating that SCFA may also contribute to in vivo colonic motility ([@r44]; [@r54]). However, no effects of SCFA on canine colonic motility were observed in in vivo studies ([@r18]).

It is obvious that the close relationship between the intestinal microbiota and host cells will have a significant impact on GI health. Gastrointestinal disease may develop due to colonization with transient pathogens, due to an overgrowth by opportunistic resident bacterial groups, or due to an altered cross-talk between the intestinal innate immune system and the commensal microbiota. Invasion with specific pathogens may profoundly disturb the intestinal epithelium by altering the structure of the GI mucosa. Enteric pathogens can penetrate into the submucosa and Peyer\'s patches, or produce exo- or enterotoxins that alter enterocyte function. Enterotoxins produced by pathogenic bacteria (e.g., enterotoxigenic *Clostridium perfringens*, and toxigenic *Clostridium difficile*) can stimulate mucosal fluid secretions, whereas villus effacement and loss of surface area will diminish mucosal absorptive capacity, resulting in diarrhea ([@r40]). A dysfunction of the mucosal barrier can lead to an increase in intestinal permeability and clinically significant bacterial translocation. Intestinal pathogens that have been associated with acute or chronic diarrhea in dogs and cats include enterotoxigenic *C. perfringens*, toxigenic *C. difficile*, *Salmonella*, *Escherichia coli* (i.e., enteropathogenic, enterotoxigenic, enterohemorrhagic, and enteroinvasive), and specific *Campylobacter* spp. (i.e., *Campylobacter jejuni*; [@r49]; [@r41]; [@r58]).

Several GI diseases of dogs and cats are associated with nonspecific alterations in the intestinal microbiota. Small intestinal dysbiosis is a common disorder that is suspected to be caused by an intestinal dysbiosis. This disorder commonly has been referred to as small intestinal bacterial overgrowth or antibiotic-responsive diarrhea, as it has been previously suggested that affected dogs harbor increased bacterial counts (i.e., \>10^5^ cfu/ml) in their duodenum ([@r3]). Patients respond favorably to antibiotics (e.g., tylosin), but diarrhea usually returns shortly after cessation of therapy ([@r79]). Recent studies found no correlation between increased duodenal bacterial counts and disease status of dogs ([@r20]). Failure of host control mechanisms that regulate bacterial counts in the small intestine may lead to more general changes in bacterial populations, causing a dysbiosis in the small intestine. These regulatory mechanisms include intestinal motility and antimicrobial substances in pancreatic and biliary secretions. Therefore, spontaneous changes in GI motility or procedures that alter the architecture of the intestine (e.g., surgical creation of intestinal loops and resection of the ileocolic valve) can predispose animals to intestinal dysbiosis ([@r75]). In exocrine pancreatic insufficiency, the defective pancreas is not capable of secreting antimicrobial peptides, and exocrine pancreatic insufficiency is often associated with an increase or compositional changes in small intestinal microbiota ([@r80]; [@r60]). These changes may lead to various mechanisms that negatively affect the function of the GI tract. Examples are the dehydroxylation of fatty acids leading to impaired fat absorption, alterations in the intestinal barrier with increased intestinal permeability, the destruction of brush border enzymes and epithelial carrier proteins, and competition for substrates leading to nutrient and vitamin malabsorption (e.g., vitamin B~12~; [@r57], [@r56]; [@r45]).

MICROBIOTA AND INFLAMMATORY BOWEL DISEASE
=========================================

There is emerging evidence implicating commensal intestinal microbiota in the pathogenesis of inflammatory bowel disease (**IBD**) in humans, dogs, and cats ([@r28]; [@r70]). The currently proposed pathogenic mechanism behind IBD involves an abnormal interaction between commensal intestinal microbiota and the intestinal immune system in genetically predisposed individuals ([@r50]). For example, genome-wide association studies in humans with Crohn\'s disease have revealed at least 33 susceptibility genes, and many of these genes are associated with a defective bacterial killing of the innate immune system (e.g., nucleotide-binding oligomerization domain containing protein 2, also known as caspase activation and recruitment domain 15; [@r50]). The microbiota is implicated in human IBD because inflammation is present in gut compartments with the greatest bacterial counts. Studies in engineered animal models with susceptibility for inflammation indicate that IBD develops only if bacteria are present ([@r50]). The cause-effect relationship between microbial alterations and inflammation is not well determined. It is suspected that intestinal inflammation causes a dysbiosis toward gram-negative bacteria (i.e., Proteobacteria), and a depletion of commensal bacterial groups may lead to a reduced capability of the intestinal microbiome to downregulate an aberrant intestinal immune response, leading to a perturbation of intestinal inflammation ([@r62]). New hypotheses indicate that *Campylobacter jejuni* and *Salmonella* gastroenteritis trigger changes in mucosal architecture and in the innate immune system, which diminish the colonization resistance of resident microbes ([@r64]). In human IBD, decreases in the phyla Firmicutes and Bacteroidetes, and increases in Proteobacteria are commonly observed. Furthermore, reductions in the diversity of *Clostridium* clusters XIVa and IV (i.e., *Ruminococcaceae*, *Faecalibacterium prausnitzii*, and *C. coccoides* subgroups) in IBD patients indicate that these bacterial groups, important producers of SCFA, play an important role in maintenance of GI health ([@r62]; [@r50]).

Recent molecular studies performed in dogs and cats have also revealed differences in the intestinal microbiome between healthy animals and IBD patients ([Table 3](#t3){ref-type="table"}). Dogs and cats with idiopathic small intestinal IBD were significantly enriched in Enterobacteriaceae compared with controls ([@r28]; [@r81]). Two other studies revealed an increase in Proteobacteria (i.e., *Pseudomonas* spp.) in the duodenum of IBD dogs ([@r29]; [@r70]). Similar to humans, IBD dogs showed a reduction in the proportions of Bacteroidales and Clostridiales (e.g., genus *Faecalibacterium*, *Ruminococcus*, and *Dorea* within the Clostridium clusters IV and XIVa; [@r29]). Reduced bacterial species richness was identified in the small intestine of IBD dogs ([@r81]; [@r14]). Compositional changes have also been observed in the large intestine of dogs and cats with chronic enteropathies. Fluorescence in situ hybridization analysis revealed greater microscopic counts of total bacteria, *Bifidobacterium* spp. and *Bacteroides* spp., in healthy cats, whereas cats with IBD had greater microscopic counts of *Desulfovibrio* spp., potential producers of toxic sulfides ([@r27]).

###### 

Microbial changes in cats and dogs with gastrointestinal disease^1^

  Species   Sampling location   Tissue type                 Disease                                 Method                                    Microbial changes in diseased animals                                                                                                        Reference
  --------- ------------------- --------------------------- --------------------------------------- ----------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------- -----------
  Cats      Small intestine     Biopsies                    IBD                                     FISH                                      Increase in Enterobacteriaceae                                                                                                               [@r28]
  Dogs      Duodenum            Biopsies                    IBD                                     16S rRNA gene clone libraries             Increase in Proteobacteria; decrease in Clostridia                                                                                           [@r70]
  Dogs      Duodenum            Mucosal/luminal brushings   IBD                                     16S rRNA gene clone libraries             Increase in Enterobacteriaceae (*Escherichia coli*); reduction in biodiversity                                                               [@r81]
  Dogs      Duodenum            Mucosal/luminal brushings   Chronic enteropathies (FRD, ARD)        16S rRNA gene clone libraries             Increase in Lactobacillales (*Streptococcus* and *Abiotrophia*)                                                                              [@r1]
  Dogs      Duodenum            Biopsies                    IBD                                     454-pyrosequencing of the 16S rRNA gene   Increase in Proteobacteria; decrease in *Faecalibacterium*, *Ruminococcus*, and *Dorea* spp. within the *Clostridium* clusters IV and XIVa   [@r29]
  Dogs      Duodenum            Biopsies                    Chronic enteropathies (SRD, FRD, ARD)   454-pyrosequencing of the 16S rRNA gene   Reduced biodiversity                                                                                                                         [@r14]
  Cats      Feces               Fecal samples               Small and large bowel IBD               FISH                                      Decreased total bacteria, *Bifidobacterium* spp. and *Bacteroides* spp.; increase in *Desulfovibrio* spp.                                    [@r27]
  Dogs      Feces               Fecal samples               Chronic diarrhea                        FISH                                      Increase in *Bacteroides*                                                                                                                    [@r30]
  Dogs      Feces               Fecal samples               Diarrhea                                T-RFLP                                    Increases in *Clostridium perfringens, Enterococcus faecalis*, and *Enterococcus faecium*                                                    [@r5]
  Dogs      Colon               Biopsies                    Granulomatous colitis of Boxer dogs     FISH                                      Intracellular translocation of adherent and invasive *E. coli*                                                                               [@r61]

^1^IBD = inflammatory bowel disease; FISH = fluorescence in situ hybridization; ARD = antibiotic responsive diarrhea; FRD = food-responsive diarrhea; SRD = steroid-responsive diarrhea; T-RFLP = terminal RFLP.

Similar to humans, studies have indicated that feline and canine IBD are likely associated with an immune dysregulation, as differential cytokine expressions have been identified in dogs and cats with chronic enteropathies ([@r48]; [@r28]; [@r38]). Several studies have evaluated expression of Toll-like receptors (**TLR**) in dogs with chronic enteropathies. Toll-like receptors are crucial members of the innate immune system. They are located on cell surfaces, recognize microbe-associated molecular patterns, and activate immune responses. Mucosal expression of TLR-2, TLR-4, and TLR-9 was increased in various dog breeds with IBD ([@r10]; [@r43]). German Shepherd dogs are predisposed to chronic enteropathies, and a recent study has revealed an increased TLR-2 and a decreased TLR-5 expression when compared with healthy Greyhound dogs ([@r1]). Furthermore, the microbiota of affected German Shepherd dogs differed from the control dogs, and was enriched in *Streptococcus* and *Abiotrophia* spp., indicating a potential interplay between resident microbiota and the innate immune system ([@r1]).

Granulomatous colitis of Boxer dogs, sometimes also referred to as histiocytic ulcerative colitis of Boxer dogs, has recently been associated with the presence of adherent and invasive *Escherichia coli* (**AIEC**; [@r61]). These AIEC isolates share similarities to AIEC isolates obtained from ileal tissues of humans with Crohn\'s disease. The inflammation responds well to antimicrobial treatment, and improvement of clinical signs correlates with the intracellular clearance of bacteria ([@r12]). Because this disease occurs almost exclusively in Boxer dogs, a genetic susceptibility has been hypothesized. A recent genome-wide analysis of affected and unaffected Boxer dogs has identified SNP in the gene encoding neutrophil cytosolic factor 2, a subunit of the NADPH complex in phagocytes ([@r12]). The defect in the NADPH complex may result in an inability to eliminate intracellular pathogens, predisposing the host to chronic infections.

SUMMARY AND CONCLUSIONS
=======================

The use of molecular tools has vastly improved our understanding of the complexity and the diversity of the intestinal microbiome of dogs and cats. These methods have allowed us to monitor and to understand microbial dynamics in response to various environmental influences (e.g., dietary changes, antibiotic treatment) and to identify bacterial groups that appear to play a key role in maintaining homeostasis and balance of the intestinal ecosystem (e.g., members of the *Clostridium* clusters XIVa and IV). These bacterial groups are often depleted in intestinal inflammation. Furthermore, recent studies have revealed differential immune responses in dogs and cats with chronic enteropathies and have also identified underlying genetic defects in the host innate immunity. Together, these findings clearly implicate an interaction of the innate immune system and commensal intestinal microbiota in the pathogenesis of canine and feline enteropathies.

Based on a presentation at the Companion Animals Symposium titled "Microbes and Health," at the Joint Annual Meeting, July 11 to 15, 2010, Denver, Colorado. The symposium was sponsored, in part, by Hill\'s Pet Nutrition Inc. (Topeka, KS) and The Procter & Gamble Company (Cincinnati, OH), with publication sponsored by the *Journal of Animal Science* and the American Society of Animal Science.
